Shanghai Kindly Medical Instruments Co Ltd
HKEX:1501
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Shanghai Kindly Medical Instruments Co Ltd
HKEX:1501
|
CN |
Wall St Price Targets
Price Targets Summary
Shanghai Kindly Medical Instruments Co Ltd
According to Wall Street analysts, the average 1-year price target for Shanghai Kindly Medical Instruments Co Ltd is 34.35 HKD with a low forecast of 34.02 HKD and a high forecast of 35.36 HKD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Shanghai Kindly Medical Instruments Co Ltd's stock price target?
Price Target
34.35
HKD
According to Wall Street analysts, the average 1-year price target for Shanghai Kindly Medical Instruments Co Ltd is 34.35 HKD with a low forecast of 34.02 HKD and a high forecast of 35.36 HKD.
What is the Revenue forecast for Shanghai Kindly Medical Instruments Co Ltd?
Projected CAGR
16%
Over the last 8 years, the compound annual growth rate for Revenue has been 29%. The projected CAGR for the next 2 years is 16%.
What is the Gross Profit forecast for Shanghai Kindly Medical Instruments Co Ltd?
Projected CAGR
-9%
Over the last 8 years, the compound annual growth rate for Gross Profit has been 30%. The projected CAGR for the next 3 years is -9%.
What is the Operating Income forecast for Shanghai Kindly Medical Instruments Co Ltd?
Projected CAGR
24%
Over the last 8 years, the compound annual growth rate for Operating Income has been 24%. The projected CAGR for the next 3 years is 24%.
What is the Pre-Tax Income forecast for Shanghai Kindly Medical Instruments Co Ltd?
Projected CAGR
-17%
Over the last 8 years, the compound annual growth rate for Pre-Tax Income has been 24%. The projected CAGR for the next 3 years is -17%.
What is the Net Income forecast for Shanghai Kindly Medical Instruments Co Ltd?
Projected CAGR
-13%
Over the last 8 years, the compound annual growth rate for Net Income has been 22%. The projected CAGR for the next 3 years is -13%.